---
document_datetime: 2023-09-21 20:18:53
document_pages: 12
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/clopidogrel-ratiopharm-gmbh-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: clopidogrel-ratiopharm-gmbh-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 5.9117143
conversion_datetime: 2025-12-24 16:37:57.627745
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
<!-- image -->

## Clopidogrel ratiopharm GmbH

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended no   | Product Information affected 3   | Summary   |
|----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IAIN/0036            | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                       | 22/08/2019 product                  | on                                          | SmPC and PL                      |           |
| IB/0035/G            | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO | 28/05/2019                          |                                             | SmPC and PL                      |           |

<!-- image -->

Medicinal product no longer authorised

<!-- image -->

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                   | authorised                                  |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------|
| IB/0034   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                                                                              | 13/04/2018 25/03/2019 SmPC and PL no longer |
| IB/0033/G | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH 23/05/2017 Medicinal product | 16/06/2017 SmPC, Labelling and PL           |

<div style=\"page-break-after: always\"></div>

| IB/0032/G         | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the   | 15/01/2016   | 02/06/2016 no   | SmPC and PL longer   | authorised                        |
|-------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-----------------|----------------------|-----------------------------------|
| IB/0031           | MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH Medicinal product                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 27/05/2015   | 02/06/2016      | SmPC and PL          |                                   |
| PSUSA/820/2 01311 | Periodic Safety Update EU Single assessment - acetylsalicylic acid / clopidogrel, clopidogrel                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 10/07/2014   | n/a             |                      | PRAC Recommendation - maintenance |

<div style=\"page-break-after: always\"></div>

| R/0027    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 20/03/2014   | 22/05/2014        | PL The CHMP recommended renewal   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------------------|-----------------------------------|
| IB/0030/G | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the | 29/04/2014   | 13/04/2015 longer | time. SmPC and PL authorised      |
| II/0023/G | MAH This was an application for a group of variations. - to introduce a new manufacturer of the active substance via the Active Substance Master File (ASMF) procedure and as a result - to change the storage conditions of the finished product B.I.a.1.b - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Introduction of a manufacturer of the AS supported by an ASMF B.II.f.1.d - Stability of FP - Change in storage conditions of the finished product or the Medicinal product                                        | 23/01/2014   | 22/05/2014 no     | SmPC, Labelling and PL            |

<div style=\"page-break-after: always\"></div>

|           | diluted/reconstituted product                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |            |            |                        |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|
| IB/0028   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                                                                              | 09/01/2014 | 22/05/2014 | SmPC and PL authorised |
| IB/0024/G | This was an application for a group of variations. B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time product | 09/12/2013 | n/a no     | longer                 |
| IB/0026/G | data This was an application for a group of variations. B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non-significant specification parameter (e.g. deletion of an obsolete parameter) Medicinal                                                                                                                                                                                                                                                                                                                      | 02/12/2013 | n/a        |                        |

<div style=\"page-break-after: always\"></div>

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IB/0022/G   | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH   | 14/11/2013         | 22/05/2014   | SmPC and PL authorised           |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------|--------------|----------------------------------|
| IA/0025     | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 05/11/2013         | n/a no       | longer                           |
| IB/0021/G   | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH Medicinal                     | 30/07/2013 product | 22/05/2014   | SmPC, Annex II, Labelling and PL |

<div style=\"page-break-after: always\"></div>

| IAIN/0020   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                  | 05/04/2013   | n/a        |                     | authorised                                                                                                                                                                                                                                                                                                                                                                                                        |
|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| N/0019      | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                | 03/12/2012   | 22/05/2014 | PL                  |                                                                                                                                                                                                                                                                                                                                                                                                                   |
| T/0018      | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 17/08/2012   | 17/09/2012 | SmPC, Labelling and |                                                                                                                                                                                                                                                                                                                                                                                                                   |
| IAIN/0017   | B.I.a.1.a - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The proposed manufacturer is part of the same pharmaceutical group as the currently approved manufacturer                                                                                                                                                                                                                                                                                                  | 04/04/2012   | n/a        | longer              |                                                                                                                                                                                                                                                                                                                                                                                                                   |
| IB/0014     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH Medicinal product | 22/07/2011   | n/a no     | SmPC                | To include information on the clopidogrel metabolism pathway, the role of CYP2C19 genetic polumorphism on clopidogrel variability of response and the potential interaction between clopidogrel and CYP2C19 inhibitors including some proton pump inhibitors. The MAH also took the oportunity to make align to align to the originator products. Furthermore the Marketing Authorisation numbers were seperated. |
| IA/0013     | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                              | 28/06/2011   | n/a        |                     |                                                                                                                                                                                                                                                                                                                                                                                                                   |

<div style=\"page-break-after: always\"></div>

| IB/0012   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH                                                           | 29/04/2011         | n/a        | SmPC, Annex II and PL longer   | To update the Summary of Product Characteristics (SmPC) and Package Leaflet to update sections 4.2 \"Posology and method of administration\", 4.4 \"Special warnings and precautions for use\", 4.5 \"Interaction with other medicinal products and other forms of interaction\" and 5.2 \"Pharmacokinetic properties\" of clopidogrel/acetylsalicylic acid (ASA) SPC to include new information on the variability of response to clopidogrel due to either genetic variations of the CYP2C19 enzyme or concomitant use of drugs that inhibit the CYP2C19 enzyme such as proton pump inhibitor (PPI). In addition, section 4.8 has been amended with minor details on the CURE study. Additional changes have been added to the SmPC and Package Leaflet in order to bring it in line with the revised QRD template (version 7.3) In addition, the deletion of DDPS number version and date was introduced in Annex IIB as requested by the EMA with the procedural announcement in October and November 2010. Minor linguistic changes have been introduced in the product information, to bring the product in line with the reference authorised   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------|------------|--------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| N/0011    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                         | 27/01/2011 product | n/a no     | PL                             | product.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| WS/0052   | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. To add a new active substance manufacturer. B.I.a.1.b - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Medicinal | 18/11/2010         | 18/11/2010 |                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | Introduction of a new manufacturer of the AS that is supported by an ASMF                                                                                                                                                                       |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| WS/0053/G | This was an application for a group of variations following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. - To change the genotoxic impurities specifications of the active substance; 21/10/2010 |

<div style=\"page-break-after: always\"></div>

|          | the approved specifications limits range                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |            |               |                                                                                                               |
|----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|---------------|---------------------------------------------------------------------------------------------------------------|
| IB/0010  | To include information on the clopidogrel metabolism pathway, the role of CYP2C19 genetic polumorphism on clopidogrel variability of response and the potential interaction between clopidogrel and CYP2C19 inhibitors including some proton pump inhibitors. The MAH also took the oportunity to make align to align to the originator products. Furthermore the Marketing Authorisation numbers were seperated. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH | 06/08/2010 | n/a longer    | SmPC, Labelling and PL authorised                                                                             |
| A20/0009 | Pursuant to Article 20 of Regulation (EC) No 726/2004 of 31 March 2004, the European Commission requested on 18 March 2010, the opinion of the CHMP on measures necessary to ensure the quality of the above mentioned medicinal product further to GMP deficiencies of the API manufacturing site Glochem Industries Ltd. (Unit II). product                                                                                                                                                                                                                                                                                                                    | 18/03/2010 | 29/03/2010 no | Please refer to the Assessment Report: Clopidogrel ratiopharm GmbH-H-1165-A20-09-Assessment Report-Article 20 |
| II/0008  | To register a revised version of the ASMF for clopidogrel besilate from the existing active substance manufacturer, introducing changes in the manufacturing process of the active substance. Medicinal                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 21/01/2010 | 04/02/2010    |                                                                                                               |

<div style=\"page-break-after: always\"></div>

|         | Quality changes                                                                                                                                                  |            |                                |                 |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|--------------------------------|-----------------|
| II/0007 | To introduce a new active substance manufacturer.                                                                                                                | 21/01/2010 | 04/02/2010                     | Quality changes |
| IA/0006 | IA_08_a_Change in BR/QC testing - repl./add. of batch control/testing site                                                                                       | 14/10/2009 | n/a authorised                 |                 |
| IA/0005 | IA_07_a_Replacement/add. of manufacturing site: Secondary packaging site IA_07_b_01_Replacement/add. of manufacturing site: Primary packaging site - Solid forms | 17/09/2009 | n/a                            |                 |
| IA/0004 | IA_07_a_Replacement/add. of manufacturing site: Secondary packaging site IA_07_b_01_Replacement/add. of manufacturing site: Primary packaging site - Solid forms | 11/09/2009 | n/a no longer                  |                 |
| IB/0003 | IB_41_a_02_Change in pack size - change in no. of units outside range of appr. pack size                                                                         | 28/08/2009 | 28/08/2009 SmPC, Labelling and |                 |
| IA/0002 | IA_08_b_02_Change in BR/QC testing - repl./add. manuf. responsible for BR - incl. BC/testing Medicinal product                                                   | 24/08/2009 | PL n/a Annex II and            |                 |